Literature DB >> 27124829

Culture-Negative Infection After Operative Fixation of Fractures.

Ida L Gitajn1, Marilyn Heng, Michael J Weaver, Lauren K Ehrlichman, Mitchel B Harris.   

Abstract

OBJECTIVES: (1) Compare the outcomes of patients with orthopaedic trauma with culture-negative infection with those with pathogens identified; (2) identify the incidence of culture-negative infection and describe the common characteristics.
DESIGN: Retrospective study.
SETTING: Two level 1 trauma centers. PATIENTS: A total of 391 patients 16 years of age or older who underwent irrigation and debridement for surgical site infection after having undergone fracture fixation were included. INTERVENTION: Patients underwent irrigation and debridement with cultures, and antibiotic therapy was initiated. MAIN OUTCOME MEASUREMENT: Treatment failure due to unsuccessful eradication of infection and time to union.
RESULTS: We found 9% incidence of culture-negative infection. Approximately one-third of patients in both groups went on to have treatment failure (25% of pathogen-specific infections, 38% of culture-negative infections, P = 0.15), and there was no difference between the 2 groups with regard to time to union (22 vs. 24 weeks, P = 0.55). More than one-third of patients required subsequent reconstructive procedure and 5% of patients in each group required amputation to control their infection. There was no difference between the groups with respect to the use of antibiotics before intervention and culture.
CONCLUSION: This study confirms the devastating effect that postoperative infections can have and suggests that, with clinical sign of infection, negative cultures do not portend a better prognosis. These entities should be treated in a similar manner to infections with positive cultures. Furthermore, we believe that future studies should not strictly rely on the presence of positive intraoperative cultures. Consensus as to what constitutes a clinical infection, in the absence of positive cultures, is needed. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27124829     DOI: 10.1097/BOT.0000000000000618

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  6 in total

1.  Fracture Related Infections and Their Risk Factors for Treatment Failure-A Major Trauma Centre Perspective.

Authors:  Victor Lu; James Zhang; Ravi Patel; Andrew Kailin Zhou; Azeem Thahir; Matija Krkovic
Journal:  Diagnostics (Basel)       Date:  2022-05-22

2.  Isothermal Microcalorimetry Improves the Time to Diagnosis of Fracture-related Infection Compared With Conventional Tissue Cultures.

Authors:  Kyle H Cichos; Clay A Spitler; Jonathan H Quade; Joseph P Johnson; Michael D Johnson; Elie S Ghanem
Journal:  Clin Orthop Relat Res       Date:  2022-04-05       Impact factor: 4.755

3.  Causative Pathogens Do Not Differ between Early, Delayed or Late Fracture-Related Infections.

Authors:  Ruth A Corrigan; Jonathan Sliepen; Maria Dudareva; Frank F A IJpma; Geertje Govaert; Bridget L Atkins; Rob Rentenaar; Marjan Wouthuyzen-Bakker; Martin McNally
Journal:  Antibiotics (Basel)       Date:  2022-07-14

4.  Diagnosing Fracture-Related Infections: Where Are We Now?

Authors:  Madeleine C Stevenson; Julia C Slater; H Claude Sagi; Federico Palacio Bedoya; Margaret V Powers-Fletcher
Journal:  J Clin Microbiol       Date:  2021-06-16       Impact factor: 11.677

5.  How Successful Is Antibiotic Treatment for Superficial Surgical Site Infections After Open Fracture? A Fluid Lavage of Open Wounds (FLOW) Cohort Secondary Analysis.

Authors:  Carlos Prada; Stephanie L Tanner; Francesc A Marcano-Fernández; Sofia Bzovsky; Emil H Schemitsch; Kyle Jeray; Brad Petrisor; Mohit Bhandari; Sheila Sprague
Journal:  Clin Orthop Relat Res       Date:  2020-12       Impact factor: 4.755

6.  Long-term outcomes after operative treatment for tibial pilon fractures.

Authors:  Quirine M J van der Vliet; Yassine Ochen; Michael F McTague; Michael J Weaver; Falco Hietbrink; Roderick M Houwert; Luke P H Leenen; Marilyn Heng
Journal:  OTA Int       Date:  2019-11-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.